US company poised to start COVID-19 vaccine safety test
A second U.S. company is poised to begin a small safety test of a vaccine against the new coronavirus.
Inovio Pharmaceuticals said Monday that it has Food and Drug Administration permission for the study in 40 healthy volunteers in Philadelphia and Kansas City, Missouri.
The study is a first step to see if the vaccine appears safe enough for larger tests needed to prove whether it will protect. Even if the research goes well, it is expected to take over a year before any vaccine could be widely available.
Last month, the first safety test in people of a different vaccine candidate began in Seattle. It was developed by the National Institutes of Health and Moderna Inc.
Numerous other research groups are attempting to make vaccines against COVID-19 using a variety of different methods in hopes at least one will offer protection.
Inovio’s approach is what’s called a DNA vaccine, made using a section of the virus’ genetic code packaged inside a piece of synthetic DNA.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Owners rescue puppy from python in backyard
EBR Sheriff's Office investigates deadly Burbank area shooting
Free COVID testing Wed-Thur at Lamar-Dixon Expo Center in Gonzales
United Kingdom approves emergency use of COVID vaccine
First US-approved vaccine to go to healthcare workers, nursing home patients
LSU loses its wide receiver shortly before game against Crimson Tide
Port Allen advances to 2nd round after huge win over Pine
U High has no problems with Evangel Christian in first round
Belaire making 1st playoff appearance in 17 years Friday
Southeastern women blow out Alcorn State on opening day of college basketball...